Koers Eidos Therapeutics, Inc.
Aandelen
EIDX
US28249H1041
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 01-03-16 |
Jonathan Fox
PSD | President | 67 | 01-10-16 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-06-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-06-16 |
Jonathan A. Barr
BRD | Director/Board Member | - | 26-01-21 |
Jonathan Fox
PSD | President | 67 | 01-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,30% | 102 mld. | |
+1,79% | 96,07 mld. | |
-1,48% | 21,66 mld. | |
-18,35% | 20,77 mld. | |
-7,89% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-26,84% | 13,79 mld. | |
+0,59% | 13,33 mld. | |
+20,86% | 10,94 mld. |